<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Vet Med Sci</journal-id>
      <journal-id journal-id-type="iso-abbrev">J. Vet. Med. Sci</journal-id>
      <journal-id journal-id-type="publisher-id">JVMS</journal-id>
      <journal-title-group>
        <journal-title>The Journal of Veterinary Medical Science</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0916-7250</issn>
      <issn pub-type="epub">1347-7439</issn>
      <publisher>
        <publisher-name>The Japanese Society of Veterinary Science</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25252640</article-id>
      <article-id pub-id-type="pmc">4349544</article-id>
      <article-id pub-id-type="publisher-id">14-0242</article-id>
      <article-id pub-id-type="doi">10.1292/jvms.14-0242</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Internal Medicine</subject>
          <subj-group>
            <subject>Note</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Restenosis after balloon valvuloplasty in a dog with pulmonary
stenosis</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>SUNAHARA</surname>
            <given-names>Hiroshi</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>FUJII</surname>
            <given-names>Yoko</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref rid="cor1" ref-type="corresp">
            <sup>*</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>SUGIMOTO</surname>
            <given-names>Keisuke</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>AOKI</surname>
            <given-names>Takuma</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>SUGAHARA</surname>
            <given-names>Gou</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>SHIROTA</surname>
            <given-names>Kinji</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <aff id="aff1"><label>1)</label>Laboratory of Surgery 1, Azabu University, 1&#x2013;17&#x2013;71
Fuchinobe, Chuo-ku, Sagamihara-shi, Kanagawa 252&#x2013;5201, Japan</aff>
        <aff id="aff2"><label>2)</label>Laboratory of Veterinary Pathology, Azabu University,
1&#x2013;17&#x2013;71 Fuchinobe, Chuo-ku, Sagamihara-shi, Kanagawa 252&#x2013;5201, Japan</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1"><label>*</label>Correspondence to: Fujii, Y., Azabu University, 1&#x2013;17&#x2013;71
Fuchinobe, Chuo-ku, Sagamihara-shi, Kanagawa 252&#x2013;5201, Japan. e-mail: <email xlink:href="fujiiy@azabu-u.ac.jp">fujiiy@azabu-u.ac.jp</email></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>23</day>
        <month>9</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>1</month>
        <year>2015</year>
      </pub-date>
      <volume>77</volume>
      <issue>1</issue>
      <fpage>95</fpage>
      <lpage>99</lpage>
      <history>
        <date date-type="received">
          <day>10</day>
          <month>5</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>03</day>
          <month>9</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9;2015 The Japanese Society of Veterinary Science</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative
Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License. </license-p>
        </license>
      </permissions>
      <abstract>
        <p>A two-month-old female Chihuahua was diagnosed as severe pulmonary valvular
stenosis (PS). Although balloon valvuloplasty (BV) was successfully performed, restenosis
was observed 19 months after the procedure. Euthanasia was chosen due to low output
syndrome during the surgical repair attempted when the dog was 5 years old. Postmortem
examination revealed markedly thickened pulmonary valve due to the increase of
extracellular matrix which might be produced by increased &#x3B1; smooth muscle actin-positive
myofibroblasts. The thickening of the valve was associated with restriction of the valve&#x2019;s
motion, resulting in restenosis in the present case. This is the first case report
documented histopathological and immunohistochemical findings of the restenotic pulmonary
valve in dogs with PS after BV.</p>
      </abstract>
      <kwd-group>
        <kwd>canine</kwd>
        <kwd>pulmonary stenosis</kwd>
        <kwd>restenosis</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p>Balloon valvuloplasty (BV) has become the first-line treatment for dogs with moderate to
severe pulmonary valvular stenosis (PS) [<xref rid="r11" ref-type="bibr">11</xref>]. A
previous study demonstrated that BV improved clinical signs and survival time [<xref rid="r1" ref-type="bibr">1</xref>], and BV has been recognized as an effective and safe
technique in humans and dogs when performed in indicated patients [<xref rid="r3" ref-type="bibr">3</xref>, <xref rid="r7" ref-type="bibr">7</xref>, <xref rid="r19" ref-type="bibr">19</xref>].</p>
    <p>Complications in long-term follow-up, such as residual pressure gradient, pulmonary valve
regurgitation and restenosis, were reported in a human study with over 10 years of follow-up
[<xref rid="r20" ref-type="bibr">20</xref>]. Frequency of restenosis in several human case
series ranged from 4.8&#x2013;21% [<xref rid="r19" ref-type="bibr">19</xref>], but reports of
long-term outcomes after BV have been limited in veterinary medicine. Small case series with
1&#x2013;6 months follow-up after BV reported that restenosis was observed in some dogs, although the
details were not discussed [<xref rid="r7" ref-type="bibr">7</xref>]. The cause of restenosis
in dogs has never been described, and no study has documented histopathological and
immunohistochemical findings of the restenotic pulmonary valve in dogs with PS after BV.</p>
    <p>A 2-month-old female Chihuahua, weighing 660 g, was referred to Azabu University Veterinary
Teaching Hospital, because of a cardiac murmur (day 1). The dog was asymptomatic, and physical
examination was unremarkable except for a grade 5/6 systolic ejection murmur at the left heart
base and systolic regurgitant murmur at the right heart apex. Thoracic radiography revealed
right ventricular and main pulmonary arterial enlargement. Normal sinus rhythm with right mean
electrical axis deviation was observed on an electrocardiogram. Echocardiography revealed
right ventricular hypertrophy and dilation, flattening of the interventricular septum,
perimembranous ventricular septal defect (VSD) with left-to-right shunt and severe pulmonary
stenosis. Ventricular septal defect was considered as relatively small on B-mode and
Color-Doppler images. Pulmonary annulus diameter was 9 mm, the same as the aortic diameter.
Pulmonary valve commissures were fused with a central orifice, and valve doming in systole was
observed (valvular stenosis). The peak instantaneous pressure gradient across the pulmonary
valve was estimated to be 92 mmHg (maximal pulmonary arterial blood flow velocity, 4.8 m/s).
Since the peak VSD flow was 2.2 m/s, the estimated pressure gradient between left and right
ventricles was 19 mmHg. No volume overload in left side of the heart was observed. The dog was
diagnosed as severe pulmonic valvular stenosis with restricted VSD. Since PS was considered to
be the major lesion in this particular case, BV was performed on day 200.</p>
    <p>Following intravenous administration of fentanyl (10 <italic>&#xB5;</italic>g/kg, Fentanyl,
Janssen Pharmaceutical, Tokyo, Japan) and midazolam (0.2 mg/kg, Dormicum, Astellas Pharma,
Tokyo, Japan), general anesthesia was maintained by isoflurane (Isoflurane, Canonsburg, PA,
U.S.A.) and fentanyl (continuous rate infusions 10 <italic>&#xB5;</italic>g/kg/hr). Cardiac
catheterization (Multipurpose catheter, Medikit Co., Tokyo, Japan) was performed through right
external jugular vein. Systolic pressure in right ventricle and main pulmonary artery were 72
and 10 mmHg, respectively. Selective right ventricular angiocardiography revealed PS with
poststenotic dilatation. Since the pulmonary valve annulus diameter was 8.5 mm, BV was
performed using a balloon (TYSHAK IIVeterinary Balloon Catheter, NuMed, Hopkinton, NY, U.S.A.)
size of 12 mm (1.4 times the width of annulus). The balloon was inflated twice until the waist
disappeared. The peak right ventricular pressure was decreased to 28 mmHg. The dog recovered
uneventfully from the anesthesia.</p>
    <p>On day 208 (a week after the procedure), echocardiographic examination using right
parasternal short-axis view revealed that the peak instantaneous pressure gradient across the
pulmonary valve decreased to 43 mmHg (maximal pulmonary arterial blood flow velocity, 3.3
m/s). Although the peak VSD flow increased to 4.7 m/s, left atrial-to-aortic root diameter
ratio, left ventricular diameter at the end-diastole (1.53 cm, 95% prediction interval;
1.67&#x2013;2.43 cm) and left ventricular end-diastolic diameter index (1.17) were within normal
range, which revealed that there was no deterioration of volume overload to the left heart.
Follow-up echocardiography was performed every 1&#x2013;3 months (<xref ref-type="fig" rid="fig_001">Fig. 1</xref><fig orientation="portrait" fig-type="figure" id="fig_001" position="float"><label>Fig. 1.</label><caption><p>The peak instantaneous pressure gradient across the pulmonary valve (mmHg) estimated by
Doppler echocardiography from day 1 to 1714. BV was performed on day 200 (arrow). The
peak pressure gradient was consistently increased over time and exceeded 80 mmHg (dotted
line) on day 768.</p></caption><graphic xlink:href="jvms-77-095-g001"/></fig>). On day 685, the pressure gradient across the pulmonary valve increased to 78 mmHg,
and because the pressure gradient was consistently increased over 80 mmHg after day 768,
atenolol was prescribed. Because exacerbation of stenosis was observed and the dog started
showing exercise intolerance, surgical repair under the cardiopulmonary bypass was performed
on day 1,717. The right ventricular outflow tract and pulmonary artery were dissected, and the
stenotic pulmonary cusp was excised. The dog developed low output syndrome after weaning from
artificial cardiopulmonary support. Since the response to medical assistance was poor,
euthanasia was chosen.</p>
    <p>After euthanasia, the heart was removed and immediately immersed in 10% neutral-buffered
formalin. The cusps of the pulmonary valve were excised from the heart, embedded in paraffin,
sectioned at 4 <italic>&#xB5;</italic>m thickness and stained with hematoxylin and eosin, alcian
blue (AB) (pH 2.5 for acid mucopolysaccharide), Masson&#x2019;s trichrome (MTC) and Elastica Van
Gieson Stains. Immunohistochemical staining were performed on the paraffin sections using an
immunoenzyme polymer method, and primary antibodies, dilutions and antigen retrieval are shown
in <xref rid="tbl_001" ref-type="table">Table 1</xref><table-wrap id="tbl_001" orientation="portrait" position="float"><label>Table 1.</label><caption><title>Primary antibodies and immunostaining protocol</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" rowspan="1" colspan="1">Antibody<sup>a)</sup></th><th align="center" rowspan="1" colspan="1">Clone</th><th align="center" rowspan="1" colspan="1">Dilution</th><th align="center" rowspan="1" colspan="1">Source<sup>b)</sup></th><th align="center" rowspan="1" colspan="1">Target</th><th align="center" rowspan="1" colspan="1">Antigen retrieval <sup>c)</sup></th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Iba-1</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">1:100</td><td align="left" valign="top" rowspan="1" colspan="1">Wako</td><td align="left" valign="top" rowspan="1" colspan="1">macrophages</td><td align="left" valign="top" rowspan="1" colspan="1">MW, 99&#xB0;C, 20 min</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">vWF</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">prediluted</td><td align="left" valign="top" rowspan="1" colspan="1">DAKO</td><td align="left" valign="top" rowspan="1" colspan="1">vascular endothelial cells</td><td align="left" valign="top" rowspan="1" colspan="1">Pepsin, 37&#xB0;C, 20 min</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">SMA</td><td align="left" valign="top" rowspan="1" colspan="1">1A4</td><td align="center" valign="top" rowspan="1" colspan="1">1:50</td><td align="left" valign="top" rowspan="1" colspan="1">DAKO</td><td align="left" valign="top" rowspan="1" colspan="1">vascular smooth muscle cells, pericytes,
myofibroblasts</td><td align="left" valign="top" rowspan="1" colspan="1">NT</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PCNA</td><td align="left" valign="top" rowspan="1" colspan="1">PC10</td><td align="center" valign="top" rowspan="1" colspan="1">1:100</td><td align="left" valign="top" rowspan="1" colspan="1">DAKO</td><td align="left" valign="top" rowspan="1" colspan="1">proliferating cells</td><td align="left" valign="top" rowspan="1" colspan="1">MW, 90&#xB0;C, 10 min</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD3</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">1:400</td><td align="left" valign="top" rowspan="1" colspan="1">DAKO</td><td align="left" valign="top" rowspan="1" colspan="1">T lymphocytes</td><td align="left" valign="top" rowspan="1" colspan="1">Pepsin, 37&#xB0;C, 20 min</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD20</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">1:400</td><td align="left" valign="top" rowspan="1" colspan="1">Thermo Fisher Scientific</td><td align="left" valign="top" rowspan="1" colspan="1">B lymphocytes</td><td align="left" valign="top" rowspan="1" colspan="1">NT</td></tr><tr><td align="left" valign="top" colspan="2" rowspan="1">Fibrinogen</td><td align="center" valign="top" rowspan="1" colspan="1">1:1000</td><td align="left" valign="top" rowspan="1" colspan="1">DAKO</td><td align="left" valign="top" rowspan="1" colspan="1">Fibrinogen, fibrin</td><td align="left" valign="top" rowspan="1" colspan="1">Trypsin, 37&#xB0;C, 30 min</td></tr></tbody></table><table-wrap-foot><p>a) vWF=von Willebrand factor; SMA=&#x3B1;-smooth muscle actin; PCNA=proliferating cell
nuclear antigen; NT=no treatment.b) Wako Pure Chemical Industries Ltd., Osaka, Japan;
Dako Denmark A/S, Glostrup, Denmark; Thermo Fisher Scientific (Anatomic Pathology),
Fremont, CA, U.S.A. c) MW=microwave, citrate buffer (PH6.0); Pepsin=0.4%Pepsin (Dako);
Trypsin=0.1% trypsin (Dako).</p></table-wrap-foot></table-wrap>. Peroxidase-conjugated anti-mouse immunoglobulin G (Histofine Simple Stain
MAX-PO (M); Nichirei, Tokyo, Japan) or peroxidase-conjugated anti-rabbit immunoglobulin G
(Histofine Simple Stain MAX-PO) ((R); Nichirei) was used as a secondary antibody. After
immunoreactions, the sections were colorized with diaminobenzidine and counterstained with
Mayer&#x2019;s hematoxylin.</p>
    <p>The pulmonary valves from three beagles (control dogs, 12&#x2013;18 months old, weighing 10.4 to
11.2 kg) without any cardiac abnormalities were examined by the same methods for comparison.
This study was approved by the Ethical Committee of Azabu University (No.1306105) and
conducted in accordance with guidelines established by the Animal Welfare Act and the NIH
Guide for Care and Use of Laboratory Animals.</p>
    <p>Macroscopically, the cusps of pulmonary valves from control dogs were thin and semilunar in
shape. The size and shape of cusps were approximately the same in each control dog. On the
other hand, cusps of the restenotic pulmonary valve of the present case were prominently
thickened, stiff and irregular in shape. Other valves including atrioventricular valves and
aortic valve from the present case were macroscopically unremarkable.</p>
    <p>Light microscopy revealed that the cusps of the pulmonary valves in control dogs were
entirely covered with a single layer of endothelial cells and composed of three distinct
layers: the fibrosa (pulmonary artery aspect), the spongiosa (inner aspect) and the
ventricularis (ventricular aspect), as in human heart [<xref rid="r2" ref-type="bibr">2</xref>] (<xref ref-type="fig" rid="fig_002">Fig. 2a</xref><fig orientation="portrait" fig-type="figure" id="fig_002" position="float"><label>Fig. 2.</label><caption><p>Histological feature of a normal cusp of the pulmonary valve from control beagle dog.
(a) Upper and lower arrows indicate the fibrosa and ventricularis of a cusp,
respectively. Asterisk showed spongiosa, which had artificially distended during tissue
processing. Hematoxylin and eosin staining. (b) Fibrosa (*) consists of thick bundles of
collagen fibers. Masson&#x2019;s trichrome. (c) Spongiosa (*) consists of fine collagen fibers,
scattered mesenchymal cells and alcian blue (AB) positive matrix. Alcian blue. (d)
Ventricularis is composed of densely arranged elastic fibers (arrow). Elastica van
Gieson. Figures (b), (c) and (d) are of the area encircled in (a). PA: pulmonary artery
aspect. RV: right ventricular aspect. Bar=800 <italic>&#xB5;</italic>m (a) and 200
<italic>&#xB5;</italic>m (b, c, d).</p></caption><graphic xlink:href="jvms-77-095-g002"/></fig>). The fibrosa was composed of bundles of collagen fibers (<xref ref-type="fig" rid="fig_002">Fig. 2b</xref>), and the spongiosa was a thin lucent layer containing
AB-positive materials, delicate collagen fibers and scattered fibroblasts (<xref ref-type="fig" rid="fig_002">Fig. 2c</xref>). This layer was well developed at the base of
the cusps. The ventricularis was thin and mainly composed of elastic fibers (<xref ref-type="fig" rid="fig_002">Fig. 2d</xref>). A few &#x3B1; smooth muscle actin (&#x3B1;SMA)-positive
cells were present beneath the surface endothelial cells in the ventricular aspect, and no
blood vessels were found in the cusps of control dogs. Few Iba-1-positive macrophages were
scattered throughout the cusps, but proliferating cells positive for proliferating nuclear
antigen (PCNA) were not detected in control pulmonary valves.</p>
    <p>In the restenotic valve of the present patient, three cusps were markedly thickened, and the
three layers were no longer distinguished. The left-facing cusp showed intense fibrosis with
focal deposition of the AB-positive matrix (<xref ref-type="fig" rid="fig_003">Fig. 3</xref><fig orientation="portrait" fig-type="figure" id="fig_003" position="float"><label>Fig. 3.</label><caption><p>The left-facing cusp of the case, showing severe fibrosis. The cusp was replaced by
dense collagen fibers seen in deep blue. The tip of the cusp (*) composed of dense
collagen fibers as well as elastic fibers. Some lucent portions protruded from the
surface of the cusp (arrows). PA: pulmonary artery aspect. RV: right ventricular
aspect. Masson&#x2019;s trichrome. Bar=400 <italic>&#xB5;</italic>m.</p></caption><graphic xlink:href="jvms-77-095-g003"/></fig>). Also, while elastofibrosis and irregular protrusions developed at the
tip of the cusp, the right-facing and non-facing cusps showed a lumpy configuration with
massive deposition of the AB-positive matrix (<xref ref-type="fig" rid="fig_004">Figs. 4</xref><fig orientation="portrait" fig-type="figure" id="fig_004" position="float"><label>Fig. 4.</label><caption><p>The non-facing cusp of the case, showing lumpy configuration. Irregular protrusions
of the valvular tissue developed from the ventricular surface of the cusp (arrows).
Asterisk indicates nodule of semilunar valve. PA: pulmonary artery aspect. RV: right
ventricular aspect. Elastica van Gieson. Bar=800 <italic>&#xB5;</italic>m.</p></caption><graphic xlink:href="jvms-77-095-g004"/></fig> and <xref ref-type="fig" rid="fig_005">5</xref><fig orientation="portrait" fig-type="figure" id="fig_005" position="float"><label>Fig. 5.</label><caption><p>Massive deposition of Alcian blue-positive matrix in the non-facing cusp of the case
(white asterisk) as shown in <xref ref-type="fig" rid="fig_004">Fig. 4</xref>. Nodule
of semilunar valve was faintly stained (black asterisk). PA: pulmonary artery aspect.
RV: right ventricular aspect. Alcian blue. Bar=400 <italic>&#xB5;</italic>m.</p></caption><graphic xlink:href="jvms-77-095-g005"/></fig>). Characteristic irregular protrusions of valvular tissue were developed
on the ventricular surface of these cusps. Multifocal proliferation of &#x3B1;SMA-positive
myofibroblasts (<xref ref-type="fig" rid="fig_006">Fig. 6a</xref><fig orientation="portrait" fig-type="figure" id="fig_006" position="float"><label>Fig. 6.</label><caption><p>Immunohistochemical findings of the non-facing cusp of the case. (a) Elongated
&#x3B1;SMA-positive myofibroblasts accumulated in the valvular tissue. Arrow indicates
valvular surface. (b) Development of small blood vessels, of which endothelium showed
positive for von Willebrand factor (small arrows). Endothelium of valvular surface was
also positive for this endothelial marker (large arrow). (c) Iba-1-positive
macrophages infiltrated in the cusps. Immunostaining for &#x3B1;SMA (a), von Willebrand
factor (b) and Iba-1 (c). Positive reaction was visualized as brown in color. Bar=100
<italic>&#xB5;</italic>m (a, b) and 50 <italic>&#xB5;</italic>m (c).</p></caption><graphic xlink:href="jvms-77-095-g006"/></fig>) and development of small blood vessels confirmed by immunostaining for
von Willebrand factor (<xref ref-type="fig" rid="fig_006">Fig. 6b</xref>) were detected in
these affected valvular tissues, particularly in the ventricular aspect. PCNA-positive spindle
cells and Iba-1 positive macrophages (<xref ref-type="fig" rid="fig_006">Fig. 6c</xref>) were
increased in number and diffusely distributed in the cusps. Except for deposition of the
AB-positive matrix, vascular development, myofibroblast proliferation and irregular
configuration of the valvular surface were more prominent in the ventricular aspect than in
the pulmonary artery aspect of the cusps, as described.</p>
    <p>In CD3 and CD20-positive cells, fibrinogen-positive matrix was not detected, neither in
control pulmonary valves nor the restenotic valve.</p>
    <p>Restenosis after BV in patients with PS is known to be one of the common complications in
human patients [<xref rid="r2" ref-type="bibr">2</xref>, <xref rid="r16" ref-type="bibr">16</xref>, <xref rid="r22" ref-type="bibr">22</xref>]. Earlier investigators
reported that inadequate balloon size and pulmonary valve dysplasia were factors that have
been related to restenosis [<xref rid="r6" ref-type="bibr">6</xref>, <xref rid="r9" ref-type="bibr">9</xref>, <xref rid="r14" ref-type="bibr">14</xref>, <xref rid="r17" ref-type="bibr">17</xref>, <xref rid="r18" ref-type="bibr">18</xref>]. In our case, pulmonary
valvular annulus did not show narrowing or hypodysplasia (Type A, according to Bussadori
<italic>et al</italic>. [<xref rid="r3" ref-type="bibr">3</xref>]), which was indicated for
BV. The recommended balloon size on the basis of pulmonary annulus diameter was 10 mm to 12 mm
in this case, so we chose an adequate balloon size (12 mm) [<xref rid="r1" ref-type="bibr">1</xref>, <xref rid="r4" ref-type="bibr">4</xref>, <xref rid="r5" ref-type="bibr">5</xref>,
<xref rid="r21" ref-type="bibr">21</xref>].</p>
    <p>The affected valve was markedly thickened due to an increased amount of the AB-positive
extracellular matrix, which was composed of acid mucopolysaccharide and collagen fibers. It
was suggested that thickening of the valve due to the increase of extracellular matrix would
be associated with narrowing of the valve opening, resulting in restenosis.
Immunohistochemical examination revealed prominently increased &#x3B1;SMA-positive myofibroblasts in
the affected valve. These myofibroblasts are known to be active forms of fibroblasts [<xref rid="r8" ref-type="bibr">8</xref>] and produce acid mucopolysaccharide and collagen
following tissue injury [<xref rid="r13" ref-type="bibr">13</xref>, <xref rid="r15" ref-type="bibr">15</xref>]. Also, the increased number of Iba-positive macrophages and development
of blood vessels in the affected valve suggested that an (inflammatory) organization process
had taken place in the injured tissue. The activated macrophages might secrete IL-6, which
activates fibroblasts [<xref rid="r12" ref-type="bibr">12</xref>], and could also be involved
in the angiogenesis observed in the affected valve.</p>
    <p>As described above, restenosis appeared to be associated with thickening of the valve induced
by activation of myofibroblasts, possibly due to (inflammatory) organization response in the
valvular injured tissue after BV. However, severity of stenosis worsened about 1.5 years
post-BV in our case. This implied that stenosis would not be caused by an acute inflammatory
response due to injury from the balloon procedure. Leslie <italic>et al</italic>. reported
that mechanical stress was partly responsible for the changes in connective tissue that occur
as a result of pressure overload [<xref rid="r10" ref-type="bibr">10</xref>]. Although the
severity was mild to moderate, residual stenosis was observed immediately after BV in our
patient. Mechanical stress might have partly contributed to remodeling of the pulmonary valve.
Vascular formation and accumulation of myofibroblasts were more prominent in the ventricular
aspect of the cusps, indicating a tissue response to the mechanical stress on the cusps.</p>
    <p>Further studies are warranted to confirm our hypothesis that mechanical stress contributes to
restenotic process and investigate the exact cause of restenosis after BV, and to develop
possible treatment options to prevent restenosis.</p>
  </body>
  <back>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r1">
        <label>1</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Berman</surname><given-names>W.</given-names><suffix>Jr</suffix></name><name><surname>Fripp</surname><given-names>R. R.</given-names></name><name><surname>Raisher</surname><given-names>B. D.</given-names></name><name><surname>Yabek</surname><given-names>S. M.</given-names></name></person-group><year>1999</year>. <article-title>Significant pulmonary valve incompetence
following oversize balloon pulmonary valveplasty in small infants: A long-term follow-up
study</article-title>. <source><italic>Catheter. Cardiovasc.
Interv.</italic></source><volume>48</volume>: <fpage>61</fpage>&#x2013;<lpage>65</lpage>. doi:
<pub-id pub-id-type="doi">10.1002/(SICI)1522-726X(199909)48:1&lt;61::AID-CCD11&gt;3.0.CO;2-E</pub-id><pub-id pub-id-type="pmid">10467072</pub-id></mixed-citation>
      </ref>
      <ref id="r2">
        <label>2</label>
        <mixed-citation publication-type="book"><person-group><name><surname>Billingham</surname><given-names>M. E.</given-names></name></person-group><year>1997</year>. Histology for Pathologists, 2nd ed., Lippincott-Raven
Publishers, New York.</mixed-citation>
      </ref>
      <ref id="r3">
        <label>3</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Bussadori</surname><given-names>C.</given-names></name><name><surname>DeMadron</surname><given-names>E.</given-names></name><name><surname>Santilli</surname><given-names>R. A.</given-names></name><name><surname>Borgarelli</surname><given-names>M.</given-names></name></person-group><year>2001</year>. <article-title>Balloon valvuloplasty in 30 dogs with
pulmonic stenosis: effect of valve morphology and annular size on initial and 1-year
outcome</article-title>. <source><italic>J. Vet. Intern.
Med.</italic></source><volume>15</volume>: <fpage>553</fpage>&#x2013;<lpage>558</lpage>. doi:
<pub-id pub-id-type="doi">10.1111/j.1939-1676.2001.tb01590.x</pub-id><pub-id pub-id-type="pmid">11817060</pub-id></mixed-citation>
      </ref>
      <ref id="r4">
        <label>4</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Estrada</surname><given-names>A.</given-names></name><name><surname>Mo&#xEF;se</surname><given-names>N. S.</given-names></name><name><surname>Erb</surname><given-names>H. N.</given-names></name><name><surname>McDonough</surname><given-names>S. P.</given-names></name><name><surname>Renaud-Farrell</surname><given-names>S.</given-names></name></person-group><year>2006</year>. <article-title>Prospective evaluation of the
balloon-to-annulus ratio for valvuloplasty in the treatment of pulmonic stenosis in the
dog</article-title>. <source><italic>J. Vet. Intern.
Med.</italic></source><volume>20</volume>: <fpage>862</fpage>&#x2013;<lpage>872</lpage>. doi:
<pub-id pub-id-type="doi">10.1111/j.1939-1676.2006.tb01799.x</pub-id><pub-id pub-id-type="pmid">16955810</pub-id></mixed-citation>
      </ref>
      <ref id="r5">
        <label>5</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Harrild</surname><given-names>D. M.</given-names></name><name><surname>Powell</surname><given-names>A. J.</given-names></name><name><surname>Tran</surname><given-names>T. X.</given-names></name><name><surname>Geva</surname><given-names>T.</given-names></name><name><surname>Lock</surname><given-names>J. E.</given-names></name><name><surname>Rhodes</surname><given-names>J.</given-names></name><name><surname>McElhinney</surname><given-names>D. B.</given-names></name></person-group><year>2010</year>. <article-title>Long-term pulmonary regurgitation
following balloon valvuloplasty for pulmonary stenosis risk factors and relationship to
exercise capacity and ventricular volume and function</article-title>.
<source><italic>J. Am. Coll. Cardiol.</italic></source><volume>55</volume>:
<fpage>1041</fpage>&#x2013;<lpage>1047</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jacc.2010.01.016</pub-id><pub-id pub-id-type="pmid">20202522</pub-id></mixed-citation>
      </ref>
      <ref id="r6">
        <label>6</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Jeffery</surname><given-names>R. F.</given-names></name><name><surname>Moller</surname><given-names>J. H.</given-names></name><name><surname>Amplatz</surname><given-names>K.</given-names></name></person-group><year>1972</year>. <article-title>The dysplastic pulmonary valve: a new
roentgenographic entity; with a discussion of the anatomy and radiology of other types
of valvular pulmonary stenosis</article-title>. <source><italic>Am. J. Roentgenol.
Radium Ther. Nucl. Med.</italic></source><volume>114</volume>:
<fpage>322</fpage>&#x2013;<lpage>339</lpage>. doi: <pub-id pub-id-type="doi">10.2214/ajr.114.2.322</pub-id><pub-id pub-id-type="pmid">5058519</pub-id></mixed-citation>
      </ref>
      <ref id="r7">
        <label>7</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Johnson</surname><given-names>M. S.</given-names></name><name><surname>Martin</surname><given-names>M.</given-names></name></person-group><year>2004</year>. <article-title>Results of balloon valvuloplasty in 40
dogs with pulmonic stenosis</article-title>. <source><italic>J. Small Anim.
Pract.</italic></source><volume>45</volume>: <fpage>148</fpage>&#x2013;<lpage>153</lpage>.
doi: <pub-id pub-id-type="doi">10.1111/j.1748-5827.2004.tb00217.x</pub-id><pub-id pub-id-type="pmid">15049573</pub-id></mixed-citation>
      </ref>
      <ref id="r8">
        <label>8</label>
        <mixed-citation publication-type="book"><person-group><name><surname>Junqueira</surname><given-names>L. C.</given-names></name><name><surname>Carnerio</surname><given-names>J.</given-names></name></person-group><year>2003</year>. Basic Histology, Text &amp; Atlas, 10th ed., McGraw-Hill
Medical, New York.</mixed-citation>
      </ref>
      <ref id="r9">
        <label>9</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Koretzky</surname><given-names>E. D.</given-names></name><name><surname>Moller</surname><given-names>J. H.</given-names></name><name><surname>Korns</surname><given-names>M. E.</given-names></name><name><surname>Schwartz</surname><given-names>C. J.</given-names></name><name><surname>Edwards</surname><given-names>J. E.</given-names></name></person-group><year>1969</year>. <article-title>Congenital pulmonary stenosis resulting
from dysplasia of valve</article-title>.
<source><italic>Circulation</italic></source><volume>40</volume>:
<fpage>43</fpage>&#x2013;<lpage>53</lpage>. doi: <pub-id pub-id-type="doi">10.1161/01.CIR.40.1.43</pub-id><pub-id pub-id-type="pmid">5792996</pub-id></mixed-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Leslie</surname><given-names>K. O.</given-names></name><name><surname>Taatjes</surname><given-names>D. J.</given-names></name><name><surname>Schwarz</surname><given-names>J.</given-names></name><name><surname>vonTurkovich</surname><given-names>M.</given-names></name><name><surname>Low</surname><given-names>R. B.</given-names></name></person-group><year>1991</year>. <article-title>Cardiac myofibroblasts express alpha
smooth muscle actin during right ventricular pressure overload in the
rabbit</article-title>. <source><italic>Am. J.
Pathol.</italic></source><volume>139</volume>: <fpage>207</fpage>&#x2013;<lpage>216</lpage>.
<pub-id pub-id-type="pmid">1853934</pub-id></mixed-citation>
      </ref>
      <ref id="r11">
        <label>11</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Locatelli</surname><given-names>C.</given-names></name><name><surname>Spalla</surname><given-names>I.</given-names></name><name><surname>Domenech</surname><given-names>O.</given-names></name><name><surname>Sala</surname><given-names>E.</given-names></name><name><surname>Brambilla</surname><given-names>P. G.</given-names></name><name><surname>Bussadori</surname><given-names>C.</given-names></name></person-group><year>2013</year>. <article-title>Pulmonic stenosis in dogs: survival and
risk factors in a retrospective cohort of patients</article-title>. <source><italic>J.
Small Anim. Pract.</italic></source><volume>54</volume>:
<fpage>445</fpage>&#x2013;<lpage>452</lpage>. doi: <pub-id pub-id-type="doi">10.1111/jsap.12113</pub-id><pub-id pub-id-type="pmid">23889710</pub-id></mixed-citation>
      </ref>
      <ref id="r12">
        <label>12</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Ma</surname><given-names>F.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Jia</surname><given-names>L.</given-names></name><name><surname>Han</surname><given-names>Y.</given-names></name><name><surname>Cheng</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Qi</surname><given-names>Y.</given-names></name><name><surname>Du</surname><given-names>J.</given-names></name></person-group><year>2012</year>. <article-title>Macrophage-stimulated cardiac fibroblast
production of IL-6 is essential for TGF &#x3B2;/Smad activation and cardiac fibrosis induced
by angiotensin II</article-title>. <source><italic>PLoS
ONE</italic></source><volume>7</volume>: <fpage>e35144</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0035144</pub-id><pub-id pub-id-type="pmid">22574112</pub-id></mixed-citation>
      </ref>
      <ref id="r13">
        <label>13</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Milara</surname><given-names>J.</given-names></name><name><surname>Serrano</surname><given-names>A.</given-names></name><name><surname>Peir&#xF3;</surname><given-names>T.</given-names></name><name><surname>Gavald&#xE0;</surname><given-names>A.</given-names></name><name><surname>Miralpeix</surname><given-names>M.</given-names></name><name><surname>Morcillo</surname><given-names>E. J.</given-names></name><name><surname>Cortijo</surname><given-names>J.</given-names></name></person-group><year>2012</year>. <article-title>Aclidinium inhibits human lung fibroblast
to myofibroblast transition</article-title>.
<source><italic>Thorax</italic></source><volume>67</volume>:
<fpage>229</fpage>&#x2013;<lpage>237</lpage>. doi: <pub-id pub-id-type="doi">10.1136/thoraxjnl-2011-200376</pub-id><pub-id pub-id-type="pmid">21957094</pub-id></mixed-citation>
      </ref>
      <ref id="r14">
        <label>14</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Musewe</surname><given-names>N. N.</given-names></name><name><surname>Robertson</surname><given-names>M. A.</given-names></name><name><surname>Benson</surname><given-names>L. N.</given-names></name><name><surname>Smallhorn</surname><given-names>J. F.</given-names></name><name><surname>Burrows</surname><given-names>P. E.</given-names></name><name><surname>Freedom</surname><given-names>R. M.</given-names></name><name><surname>Moes</surname><given-names>C. A.</given-names></name><name><surname>Rowe</surname><given-names>R. D.</given-names></name></person-group><year>1987</year>. <article-title>The dysplastic pulmonary valve:
echocardiographic features and results of balloon dilatation</article-title>.
<source><italic>Br. Heart J.</italic></source><volume>57</volume>:
<fpage>364</fpage>&#x2013;<lpage>370</lpage>. doi: <pub-id pub-id-type="doi">10.1136/hrt.57.4.364</pub-id><pub-id pub-id-type="pmid">2953383</pub-id></mixed-citation>
      </ref>
      <ref id="r15">
        <label>15</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Ohkawa</surname><given-names>T.</given-names></name><name><surname>Ueki</surname><given-names>N.</given-names></name><name><surname>Taguchi</surname><given-names>T.</given-names></name><name><surname>Shindo</surname><given-names>Y.</given-names></name><name><surname>Adachi</surname><given-names>M.</given-names></name><name><surname>Amuro</surname><given-names>Y.</given-names></name><name><surname>Hada</surname><given-names>T.</given-names></name><name><surname>Higashino</surname><given-names>K.</given-names></name></person-group><year>1999</year>. <article-title>Stimulation of hyaluronan synthesis by
tumor necrosis factor-alpha is mediated by the p50/p65 NF-kappa B complex in MRC-5
myofibroblasts</article-title>. <source><italic>Biochim. Biophys.
Acta</italic></source><volume>1448</volume>: <fpage>416</fpage>&#x2013;<lpage>424</lpage>. doi:
<pub-id pub-id-type="doi">10.1016/S0167-4889(98)00155-4</pub-id><pub-id pub-id-type="pmid">9990294</pub-id></mixed-citation>
      </ref>
      <ref id="r16">
        <label>16</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Peterson</surname><given-names>C.</given-names></name><name><surname>Schilthuis</surname><given-names>J. J.</given-names></name><name><surname>Dodge-Khatami</surname><given-names>A.</given-names></name><name><surname>Hitchcock</surname><given-names>J. F.</given-names></name><name><surname>Meijboom</surname><given-names>E. J.</given-names></name><name><surname>Bennink</surname><given-names>G. B.</given-names></name></person-group><year>2003</year>. <article-title>Comparative long-term results of surgery
versus balloon valvuloplasty for pulmonary valve stenosis in infants and
children</article-title>. <source><italic>Ann. Thorac.
Surg.</italic></source><volume>76</volume>: <fpage>1078</fpage>&#x2013;<lpage>1082</lpage>.
doi: <pub-id pub-id-type="doi">10.1016/S0003-4975(03)00678-7</pub-id><pub-id pub-id-type="pmid">14529989</pub-id></mixed-citation>
      </ref>
      <ref id="r17">
        <label>17</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Radtke</surname><given-names>W.</given-names></name><name><surname>Keane</surname><given-names>J. F.</given-names></name><name><surname>Fellows</surname><given-names>K. E.</given-names></name><name><surname>Lang</surname><given-names>P.</given-names></name><name><surname>Lock</surname><given-names>J. E.</given-names></name></person-group><year>1986</year>. <article-title>Percutaneous balloon valvotomy of
congenital pulmonary stenosis using oversized balloons</article-title>.
<source><italic>J. Am. Coll. Cardiol.</italic></source><volume>8</volume>:
<fpage>909</fpage>&#x2013;<lpage>915</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0735-1097(86)80434-X</pub-id><pub-id pub-id-type="pmid">3760363</pub-id></mixed-citation>
      </ref>
      <ref id="r18">
        <label>18</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Rao</surname><given-names>P. S.</given-names></name></person-group><year>1987</year>. <article-title>Influence of balloon size on short-term
and long-term results of balloon pulmonary valvuloplasty</article-title>.
<source><italic>Tex. Heart Inst. J.</italic></source><volume>14</volume>:
<fpage>57</fpage>&#x2013;<lpage>61</lpage>. <pub-id pub-id-type="pmid">15227331</pub-id></mixed-citation>
      </ref>
      <ref id="r19">
        <label>19</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Rao</surname><given-names>P. S.</given-names></name></person-group><year>2007</year>. <article-title>Percutaneous balloon pulmonary
valvuloplasty: state of the art</article-title>. <source><italic>Catheter. Cardiovasc.
Interv.</italic></source><volume>69</volume>: <fpage>747</fpage>&#x2013;<lpage>763</lpage>.
doi: <pub-id pub-id-type="doi">10.1002/ccd.20982</pub-id><pub-id pub-id-type="pmid">17330270</pub-id></mixed-citation>
      </ref>
      <ref id="r20">
        <label>20</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Rao</surname><given-names>P. S.</given-names></name><name><surname>Galal</surname><given-names>O.</given-names></name><name><surname>Patnana</surname><given-names>M.</given-names></name><name><surname>Buck</surname><given-names>S. H.</given-names></name><name><surname>Wilson</surname><given-names>A. D.</given-names></name></person-group><year>1998</year>. <article-title>Results of three to 10 year follow up of
balloon dilatation of the pulmonary valve</article-title>.
<source><italic>Heart</italic></source><volume>80</volume>:
<fpage>591</fpage>&#x2013;<lpage>595</lpage>. <pub-id pub-id-type="pmid">10065029</pub-id></mixed-citation>
      </ref>
      <ref id="r21">
        <label>21</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Rao</surname><given-names>P. S.</given-names></name><name><surname>Thapar</surname><given-names>M. K.</given-names></name><name><surname>Kutayli</surname><given-names>F.</given-names></name></person-group><year>1988</year>. <article-title>Causes of restenosis after balloon
valvuloplasty for valvular pulmonary stenosis</article-title>. <source><italic>Am. J.
Cardiol.</italic></source><volume>62</volume>: <fpage>979</fpage>&#x2013;<lpage>982</lpage>.
doi: <pub-id pub-id-type="doi">10.1016/0002-9149(88)90909-5</pub-id><pub-id pub-id-type="pmid">3177247</pub-id></mixed-citation>
      </ref>
      <ref id="r22">
        <label>22</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Voet</surname><given-names>A.</given-names></name><name><surname>Rega</surname><given-names>F.</given-names></name><name><surname>de Bruaene</surname><given-names>A. V.</given-names></name><name><surname>Troost</surname><given-names>E.</given-names></name><name><surname>Gewillig</surname><given-names>M.</given-names></name><name><surname>Van Damme</surname><given-names>S.</given-names></name><name><surname>Budts</surname><given-names>W.</given-names></name></person-group><year>2012</year>. <article-title>Long-term outcome after treatment of
isolated pulmonary valve stenosis</article-title>. <source><italic>Int. J.
Cardiol.</italic></source><volume>156</volume>: <fpage>11</fpage>&#x2013;<lpage>15</lpage>.
doi: <pub-id pub-id-type="doi">10.1016/j.ijcard.2010.10.038</pub-id><pub-id pub-id-type="pmid">21078529</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
